Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ibrahim M Ibrahim

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Biomaterials|September 1, 2019
Synthesis of a long acting nanoformulated emtricitabine ProTideDhruvkumar Soni, Aditya N Bade, Nagsen Gautam, et al.
Journal of Biomolecular Structure & Dynamics|December 7, 2023
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitorsAbdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar, et al.
Future Medicinal Chemistry|November 13, 2023
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-<i>d</i>]pyrimidineSouad A El-Metwally, Hazem Elkady, Mohamed Hagras, et al.
Molecular Diversity|May 10, 2023
New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFR<sup>T790M</sup>: in silico and in vitro evaluationIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
RSC Advances|April 29, 2026
Bacterial metabolite-directed synthesis of biogenic TiO<sub>2</sub>-Zn nanocomposites: characterization and multifunctional biomedical evaluationIbrahim M Ibrahim, Hanadi A Alahmadi, Anes A Al-Sharqi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 24, 2022
Discovery of new 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as anticancer agents targeting EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>Ahmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Computers in Biology and Medicine|August 18, 2023
Simulation of gold nanoparticle movement through normal and cancer cell membranesAbdo A Elfiky, Ibrahim M Ibrahim, Ahmed M Elghareib, et al.
Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.
Plos One|January 30, 2023
New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studiesAhmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Biomaterials|September 1, 2019
Synthesis of a long acting nanoformulated emtricitabine ProTideDhruvkumar Soni, Aditya N Bade, Nagsen Gautam, et al.
Journal of Biomolecular Structure & Dynamics|December 7, 2023
QSAR-driven screening uncovers and designs novel pyrimidine-4,6-diamine derivatives as potent JAK3 inhibitorsAbdelmoujoud Faris, Ibrahim M Ibrahim, Radwan Alnajjar, et al.
Future Medicinal Chemistry|November 13, 2023
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-<i>d</i>]pyrimidineSouad A El-Metwally, Hazem Elkady, Mohamed Hagras, et al.
Molecular Diversity|May 10, 2023
New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFR<sup>T790M</sup>: in silico and in vitro evaluationIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.
Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.
RSC Advances|April 29, 2026
Bacterial metabolite-directed synthesis of biogenic TiO<sub>2</sub>-Zn nanocomposites: characterization and multifunctional biomedical evaluationIbrahim M Ibrahim, Hanadi A Alahmadi, Anes A Al-Sharqi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|August 24, 2022
Discovery of new 1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidine derivatives as anticancer agents targeting EGFR<sup>WT</sup> and EGFR<sup>T790M</sup>Ahmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Computers in Biology and Medicine|August 18, 2023
Simulation of gold nanoparticle movement through normal and cancer cell membranesAbdo A Elfiky, Ibrahim M Ibrahim, Ahmed M Elghareib, et al.
Future Medicinal Chemistry|July 19, 2023
New theobromine derivatives inhibiting VEGFR-2: design, synthesis, antiproliferative, docking and molecular dynamics simulationsHazem A Mahdy, Hazem Elkady, Mohammed S Taghour, et al.
Plos One|January 30, 2023
New [1,2,4]triazolo[4,3-c]quinazolines as intercalative Topo II inhibitors: Design, synthesis, biological evaluation, and in silico studiesAhmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.
Pageof 18